Instant paralysis from new vaccine. Tens of children affected.

Minimum of 40 Children Paralyzed After New Meningitis Vaccine

Jan 6th, 2013 | By | Category: Christina England, Top Stories
This child had a reaction to a new meningitis vaccine.
This child had a reaction to a new meningitis vaccine.
On December 20, 2012, a vaccination tragedy hit the small village of Gouro, located in northern Chad, Africa. According to the newspaper La Voix, out of five hundred children who received the new meningitis vaccine MenAfriVac, at least 40 of them between the ages of 7 and 18 have become paralyzed. Those children also suffered hallucinations and convulsions.
Since this report, the true extent of this tragedy is coming to light, as parents of these vaccinated children have reported yet more injuries. The authorities in the area are shaken, as citizens set fire to a sanitary administration vehicle in a demonstration of their frustration and anger at the government’s negligence.[1]
“We wish that our children would get their health back,” shared the parent of a sick child.

THE MENAFRIVAC VACCINE

MenAfriVac is a new vaccine manufactured by Serum Institute of India Limited. According to The Meningitis Vaccine Project (MVP), it is the first vaccine to gain approval to travel outside the cold chain, meaning that the vaccine can be transported without refrigeration or ice packs for up to four days:
“The meningitis A vaccine known as MenAfriVac®, created to meet the needs of Africa’s meningitis belt, can now be kept in a controlled temperature chain (CTC) at temperatures of up to 40°C for up to four days, a decision that could help increase campaign efficiency and coverage and save funds normally spent maintaining the challenging cold chain during the “last mile” of vaccine delivery.” [2]
The data on the MenAfriVac vaccine is further backed by the World Health Organization’s website [3] and the Bill and Melinda Gates Foundation website. [4]
So, why does this information differ vastly from the information given on the manufacturer’s website? Serum Institute of India Ltd. stated under the section marked STORAGE:
“MenAfriVac should be stored and transported between 2-8ÂșC. Protect from light. The diluent should be stored at 25°C. It is recommended to protect the reconstituted vaccine from direct sunlight. Do not exceed the expiry date stated on the external packaging.” [5]

http://vactruth.com/2013/01/06/paralyzed-after-meningitis-vaccine/?utm_source=The+Vaccine+Truth+Newsletter&utm_campaign=f397fd3e4c-01_06_2013_paralyzed&utm_medium=email